Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 150 (RNA5SP150)

Target
RNA5SP150
Molecular classification
Pseudogene, rRNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 150 (RNA5SP150) is classified as a **processed pseudogene** derived from the 5S ribosomal RNA gene family[4][2][6][8]. While canonical 5S ribosomal RNA is a vital structural component of the large ribosomal subunit involved in protein synthesis[1][3][7][9], **RNA5SP150 is a non-functional copy** (pseudogene) of the 5S rRNA gene. Pseudogenes like RNA5SP150 arise through duplication or retrotransposition events and usually lack the ability to code for a functional RNA due to mutations or loss of regulatory elements[6][8]. There is no evidence that RNA5SP150 plays an active biological role, interacts with drugs, or is a therapeutic target. Its clinical or biological significance is limited to use as a reference in genomic studies distinguishing coding genes from pseudogenes. While some pseudogenes are gaining attention in cancer research for their potential regulatory roles[10], **no functional or disease relevance has been established for RNA5SP150 to date**. No direct disease association; some pseudogene expressions are studied in cancer biology[10], but no evidence specific for RNA5SP150. This entry is **not a canonical drug target** (e.g., not a receptor, enzyme, transporter, or transcription factor). It is a processed RNA pseudogene, and not functional as a protein or regulatory RNA[2][4][6]. If the request intended a ribosomally functional 5S rRNA, or a protein target, those are distinct (see canonical 5S ribosomal RNA)[1][3][7][9]. "is_incorrect:true" because RNA5SP150 is not a typical therapeutic or targetable molecule. If searching for a functional ribosomal target, this is not the correct entity. **RNA, 5S ribosomal pseudogene 150** (RNA5SP150) is a human processed pseudogene derivative of the 5S ribosomal RNA gene, lacking functional or therapeutic relevance as a molecular drug target. It is non-coding, classified as a pseudogene, and presently has no established role in disease, therapy, or biomarker science[2][4][6][8].

Other names
RNA5SP150RN5S150RNA, 5S ribosomal 150

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 150 (RNA5SP150).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 150 (RNA5SP150).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call